Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

remedica ltd - cipru - pazopanibum - compr. film. - 400mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

remedica ltd - cipru - pazopanibum - compr. film. - 200mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

remedica ltd - cipru - pazopanibum - compr. film. - 400mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza

Europese Unie - Roemeens - EMA (European Medicines Agency)

merck europe b.v. - tepotinib hydrochloride monohydrate - carcinom, pulmonar non-celulă mică - agenți antineoplazici - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.

Moldavië - Roemeens - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

laboratoire innotech international - benzalkonii chloridum - capsule moi vaginale - 18,9 mg

Europese Unie - Roemeens - EMA (European Medicines Agency)

swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - agenți antineoplazici - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.

Europese Unie - Roemeens - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - agenți antineoplazici - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Moldavië - Roemeens - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

farmaprim srl - denumirea comuna internationala - ovule - 100 mg

Moldavië - Roemeens - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

farmaprim srl - denumirea comuna internationala - ovule - 500 mg

Moldavië - Roemeens - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

balkanpharma razgrad ad - fluconazolum - capsule - 100 mg